Stay updated on BMS-986249 Study Alone & With Nivolumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the BMS-986249 Study Alone & With Nivolumab in Solid Tumors Clinical Trial page.

Latest updates to the BMS-986249 Study Alone & With Nivolumab in Solid Tumors Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedAdded a comprehensive results section with a 'Results Posted' date and detailed adverse events/outcomes across Part 1 and Part 2, including definitions for AEs/SAEs and DLTs; removed several older efficacy and PK endpoints such as ORR, DOR, PFS, TTR, Cmax, Tmax, and related PK/PD measures.SummaryDifference3%

- Check19 days agoChange DetectedRemoved the government funding/operating status notice from the page. The study details and locations remain unchanged.SummaryDifference0.2%

- Check27 days agoChange DetectedResults status updated from No Results Posted to Results Submitted for this study, indicating that trial results have been submitted.SummaryDifference0.0%

- Check41 days agoChange DetectedNo significant additions or deletions were detected; the Study Details page content and layout appear unchanged across the screenshots. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check62 days agoChange DetectedNew operating-status notice and version update to v3.2.0; previous v3.1.0 version tag removed.SummaryDifference3%

- Check70 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.1%

Stay in the know with updates to BMS-986249 Study Alone & With Nivolumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BMS-986249 Study Alone & With Nivolumab in Solid Tumors Clinical Trial page.